Le Lézard
Classified in: Health
Subject: LAW

If you are a dentist or orthodontist who purchased Invisalign directly from Align, a class action lawsuit may affect your rights


SAN FRANCISCO, Jan. 2, 2024 /PRNewswire/ --

A federal court directed this Notice. This is not a solicitation from a lawyer.

LEGAL RIGHTS and OPTIONS

Do Nothing: Stay in this lawsuit. Await the outcome. Give up certain rights. By doing nothing, you remain a class member in this class action lawsuit. If the Plaintiffs obtain money, either because of trial or settlement, you may be able to share in that money, and will be notified of how to obtain your share. If the case proceeds to trial and the Class does not prevail, you will be bound by that judgment. If you stay in the Class, you will be bound by all Orders the Court issues and judgments the Court makes in this class action. By staying in the Class, you give up any rights to sue Align separately for the same legal claims about Invisalign Aligners in this lawsuit.

Exclude Yourself: Get out of this lawsuit. Give up right to share in money obtained from it. Keep your legal rights. You may request to be excluded from this lawsuit. The Court will exclude from the Class any member who requests exclusion. This is the only way you can preserve any right you have to be part of another potential lawsuit seeking money for legal claims arising out of the facts alleged in this lawsuit about Invisalign Aligners. If you timely request exclusion ("opt out"), you will not be legally bound by the Court's judgments in this class action, will no longer be part of this lawsuit, and you will not be able to share in any money that the Class may obtain from any trial or settlement in this lawsuit. If you would like to opt out, you must send a written "Request for Exclusion" to the Class Administrator. To be valid, your Request for Exclusion must be postmarked by March 15, 2024, and mailed to: Align Direct Purchaser Antitrust Exclusion Request, c/o Class Administrator, P.O. Box 2418, Portland, OR 97208-2418. 

Lawyers must prove the legal claims about Invisalign Aligners against Align at a trial set to start on May 13, 2024 in the United States District Court for Northern District of California, Phillip Burton Federal Building & United States Courthouse, 450 Golden Gate Avenue, San Francisco, CA 94102 in Courtroom 4. If money is obtained from Align, and you remain in the Class, you will be notified about how to ask for a share. There is no guarantee that the Plaintiffs will win or that they will get any money for the Class.

Note: The date and time of the trial may change without further notice to the class. You should check www.aligndirectpurchaserantitrust.com to confirm the date of the trial has not changed.

Any questions? Visit www.aligndirectpurchaserantitrust.com or call toll free 1-888-803-3968.

SOURCE United States District Court, Northern District of California


These press releases may also interest you

at 14:53
Blue Shield of California today announced the appointment of two senior executives to help the nonprofit health plan accelerate its ambitious plans to transform the healthcare system and bolster its growth plans....

at 14:45
Prominently featured in The Inner Circle, Anika Chowhan is acknowledged as a Most Trusted Healthcare Professional for her contributions to Pediatrics. Dr. Chowhan received a Bachelor of Arts degree at the University of Berkeley and earned a Medical...

at 14:45
Prominently featured in The Inner Circle, Harry D. Kipperman, MD is acknowledged as a Pinnacle Lifetime Member for his contributions in Pediatrics. Dr. Kipperman, a distinguished pediatrician with a special focus on newborns and childhood conditions...

at 14:38
Renal Research Institute (RRI), a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, today announced together with the Karolinska Institutet a joint symposium, "Prevention of CKD progression: the impact...

at 14:33
A study published today in Nature Medicine found that a novel neuroprotective drug candidate, LM11A-31, was safe and well-tolerated following dosing for 26 weeks in patients with mild to moderate Alzheimer's disease. LM11A-31 also slowed the...

at 14:09
J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and United Al Saqer Group announced today Rayees Rahman of Harmonic Discovery as the winner of the inaugural J.P. Morgan Asset Management: Life Sciences Innovation Summit. Harmonic...



News published on and distributed by: